相关实验视频

Updated: Jan 20, 2026

Protective Efficacy and Pulmonary Immune Response Following Subcutaneous and Intranasal BCG Administration in Mice
06:32

Protective Efficacy and Pulmonary Immune Response Following Subcutaneous and Intranasal BCG Administration in Mice

Published on: September 19, 2016

11.0K

鼻内BCG疫苗接种在山羊模型中诱导了对结核的全身和肺粘膜免疫反应

Patricia Cuenca-Lara1,2, Miriam Blay-Benach1,2, Zoraida Cervera1,2

  • 1Unitat Mixta d'Investigació Institut de Recerca i Tecnologia Agroalimentàries (IRTA)-UAB en Sanitat Animal, CReSA, Campus de la Universitat Autònoma de Barcelona (UAB), Bellaterra, Catalonia, Spain.

Frontiers in immunology
|January 19, 2026
PubMed
概括

羊的鼻腔BCG接种增强了感染部位对结核病 (TB) 的早期免疫反应. 这种呼吸道粘膜输送策略显示出开发有效结核病疫苗的潜力.

关键词:
在BCG中,BCG是BCG.膜细胞巨细胞动物模型动物模型一只山羊,一只山羊.热性失活的Mycobacterium bovis菌种的存在粘膜免疫力 粘膜免疫力粘膜疫苗的使用方法结核病是一种肺结核病.

更多相关视频

Intranasal Immunization with BCG in a Mouse Model02:16

Intranasal Immunization with BCG in a Mouse Model

793
Intranasal Administration of Recombinant Influenza Vaccines in Chimeric Mouse Models to Study Mucosal Immunity10:39

Intranasal Administration of Recombinant Influenza Vaccines in Chimeric Mouse Models to Study Mucosal Immunity

Published on: June 25, 2015

13.1K

相关概念视频

Protective Efficacy and Pulmonary Immune Response Following Subcutaneous and Intranasal BCG Administration in Mice06:32

Protective Efficacy and Pulmonary Immune Response Following Subcutaneous and Intranasal BCG Administration in Mice

We herein detail the methodology followed to compare protective efficacy and lung immune response induced by intranasal and subcutaneous immunization with BCG in mouse model. Our results show the benefits of pulmonary vaccination and suggest a role for IL17-mediated response in vaccine-induced...
11.0K
Intranasal Immunization with BCG in a Mouse Model02:16

Intranasal Immunization with BCG in a Mouse Model

This video demonstrates intranasal BCG immunization in mice, activating both innate and adaptive immune responses, leading to the development of lung-resident memory T cells and effector B cells, thus enhancing protection against Mycobacterium...
793
Intranasal Administration of Recombinant Influenza Vaccines in Chimeric Mouse Models to Study Mucosal Immunity10:39

Intranasal Administration of Recombinant Influenza Vaccines in Chimeric Mouse Models to Study Mucosal Immunity

There is an overall lack of knowledge about how vaccines work. Here we propose the combined use of reverse genetics and bone marrow chimeric mice to gain insight into the early host immune responses to vaccines with a special focus on dendritic cells and T cell...
13.1K
Evaluation of Vaccine-Induced Immunity Against Bacterial Infection in a Mouse Model08:18

Evaluation of Vaccine-Induced Immunity Against Bacterial Infection in a Mouse Model

In this video, we describe a protocol to test the efficacy of an acellular pertussis vaccine against Bordetella pertussis infection in mice. Post-vaccination, the mice were subjected to infection, and their tissue homogenate was cultured to analyze the bacterial colonies as a readout of the vaccine-induced protective...
767
Intranasal Immunization and Milk Collection in Studies of Maternal Immunization in New Zealand White Rabbits (Oryctolagus cuniculus)13:00

Intranasal Immunization and Milk Collection in Studies of Maternal Immunization in New Zealand White Rabbits (Oryctolagus cuniculus)

This article describes and demonstrates the administration of intranasal vaccines and the collection of milk from lactating rabbits (Oryctolagus cuniculus) as a means to assess mucosal immunity in a translationally appropriate model of maternal immunization.
4.0K
Cationic Nanoemulsion-Encapsulated Retinoic Acid as an Adjuvant to Promote OVA-Specific Systemic and Mucosal Responses06:02

Cationic Nanoemulsion-Encapsulated Retinoic Acid as an Adjuvant to Promote OVA-Specific Systemic and Mucosal Responses

In this protocol, we developed a cationic nanoemulsion-encapsulated retinoic acid (RA) to be used as an adjuvant to promote antigen-specific systemic and mucosal responses. By adding the FDA-approved RA to the nanoemulsion, antigen-specific sIgA was promoted in the vagina and small intestine after intramuscular injection of the...
1.2K